Search

Author/Creator Yoganathan, Nathan

1. [O2–14–02]: PRECLINICAL ASSESSMENT OF KAL‐ABP TARGET ENGAGEMENT AND EFFICACY USING PET, MRI AND CSF BIOMARKERS. (1st July 2017)

Authors:
Kang, Min Su; Shin, Monica; Collins, Louis; Massarweh, Gassan; Soucy, Jean‐Paul; Brown, Leslie; Delaney, Christie; Pelletier, Alex; Haqqani, Arsalan; Durocher, Yves; Rennie, Kerry; Stanimirovic, Danica; Chakravarthy, Balu; Waterston, Michael; Yoganathan, Nathan; Cuello, Claudio; Gauthier, Serge; ...
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 11
Page Start:
P591
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. [P2–054]: BRAIN DELIVERY OF AN AMYLOID‐β OLIGOMER (AβO)‐TARGETING PEPTIDE‐THERAPEUTIC BY A NOVEL BLOOD‐BRAIN BARRIER (BBB)‐CROSSING DOMAIN ANTIBODY. (1st July 2017)

Authors:
Chakravarthy, Balu; Atkinson, Trevor; Brown, Leslie; Menard, Michel; Brunette, Eric; Pelletier, Alex; Jiang, Susan; Baumann, Ewa; Ball, Marguerite; Delaney, Christie; Ding, Wen; Star, Alexandra; Rosa‐Neto, Pedro; Waterston, Michael; Yoganathan, Nathan; Parat, Marie; Grazzini, Eric; Haqqani, Arsal...
Journal:
Alzheimer's & dementia
Issue:
Volume 13:Supplement 7S(2017)Part 12
Page Start:
P625
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. P1‐072: PRE‐CLINICAL CHARACTERIZATION OF HUMANIZED, BLOOD‐BRAIN BARRIER (BBB)‐PENETRATING, AMYLOID‐β (Aβ) OLIGOMER‐TARGETING FUSION PROTEIN. (1st July 2006)

Authors:
Rennie, Kerry; Atkinson, Trevor; Brown, Leslie; Menard, Michel; Brunette, Eric; Pelletier, Alex; Jiang, Susan; Baumann, Ewa; Delaney, Christie; Grazzini, Eric; Haqqani, Arsalan; Lessard, Etienne; Rosa-Neto, Pedro; Gillard, John; Yoganathan, Nathan; Tiwari, Krishnaraj; Paquette, Donald; Patel, Meh...
Journal:
Alzheimer's & dementia
Issue:
Volume 14:Supplement 7S(2018)Part 5
Page Start:
P298
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. Issue 5 (May 2022)

Authors:
Kang, Min Su; Shin, Monica; Ottoy, Julie; Aliaga, Arturo Aliaga; Mathotaarachchi, Sulantha; Quispialaya, Kely; Pascoal, Tharick A; Collins, D Louis; Chakravarty, M. Mallar; Mathieu, Axel; Sandelius, Åsa; Blennow, Kaj; Zetterberg, Henrik; Massarweh, Gassan; Soucy, Jean-Paul; Cuello, A Claudio; Gau...
Journal:
Journal of cerebral blood flow & metabolism
Issue:
Volume 42:Issue 5(2022)
Page Start:
788
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Pre‐clinical development of a blood‐brain barrier (BBB)‐penetrating anti‐amyloid‒β fusion protein: Nonhuman/Target identification and validation studies: Amyloid. (7th December 2020)

Authors:
Chakravarthy, Balu; Comas, Rosa; Atkinson, Trevor; Menard, Michel; Brunette, Eric; Jiang, Susan; Haukenfrers, Julie; Charlebois, Claudie; Delaney, Christie; Dudani, Renu; Aylsworth, Amy; Tauskela, Joseph; Haqqani, Arsalan; Rennie, Kerry; Pon, Robert; Agbayani, Gerard; Bihun, Craig; Akache, Bassel...
Journal:
Alzheimer's & dementia
Issue:
Volume 16(2020)Supplement 9
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗